Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant MAD2L2 anticorps

L’anticorps Lapin Monoclonal anti-MAD2L2 a été validé pour WB, ELISA, IF et IHC. Il convient pour détecter MAD2L2 dans des échantillons de Humain.
N° du produit ABIN7127607

Aperçu rapide pour Recombinant MAD2L2 anticorps (ABIN7127607)

Antigène

Voir toutes MAD2L2 Anticorps
MAD2L2 (MAD2 Mitotic Arrest Deficient-Like 2 (MAD2L2))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 45
  • 14
  • 12
  • 1
Humain

Hôte

  • 44
  • 3
Lapin

Clonalité

  • 35
  • 12
Monoclonal

Conjugué

  • 22
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp MAD2L2 est non-conjugé

Application

  • 35
  • 15
  • 14
  • 13
  • 12
  • 9
  • 6
  • 4
  • 4
  • 3
  • 2
  • 1
Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunohistochemistry (IHC)

Clone

4D8
  •  Réactivité croisée

    Humain

    Purification

    Affinity-chromatography

    Immunogène

    A synthesized peptide derived from human Mad2L2

    Isotype

    IgG
  • Indications d'application

    Recommended dilution: WB:1:500-1:5000, IHC:1:50-1:200, IF:1:20-1:200,

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène

    MAD2L2 (MAD2 Mitotic Arrest Deficient-Like 2 (MAD2L2))

    Autre désignation

    MAD2L2

    Sujet

    Background: Adapter protein able to interact with different proteins and involved in different biological processes. Mediates the interaction between the error-prone DNA polymerase zeta catalytic subunit REV3L and the inserter polymerase REV1, thereby mediating the second polymerase switching in translesion DNA synthesis. Translesion DNA synthesis releases the replication blockade of replicative polymerases, stalled in presence of DNA lesions. May also regulate another aspect of cellular response to DNA damage through regulation of the JNK-mediated phosphorylation and activation of the transcriptional activator ELK1. Inhibits the FZR1- and probably CDC20-mediated activation of the anaphase promoting complex APC thereby regulating progression through the cell cycle. Regulates TCF7L2-mediated gene transcription and may play a role in epithelial-mesenchymal transdifferentiation.

    Aliases: Mitotic spindle assembly checkpoint protein MAD2B (Mitotic arrest deficient 2-like protein 2) (MAD2-like protein 2) (REV7 homolog) (hREV7), MAD2L2, MAD2B REV7

    UniProt

    Q9UI95
Vous êtes ici:
Chat with us!